Marchesi Vincent T

Avg. Two Year Performance

134% Avg. Purchase Return
53% Compound
< 1% Avg. Sale Return
0% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(4%)(2%)7%51%134%
Purchase Success Rate0 of 31 of 32 of 32 of 32 of 3
Average Sale Return< 1%< 1%(3%)(2%)< 1%
Sale Success Rate1 of 122 of 121 of 121 of 121 of 12

Exelixis, Inc.

Drugs » Biotechnology

Director:

Holdings: 93.99K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--